Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Razan Mohty

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Hematology/Oncology and Stem Cell Therapy|November 17, 2022
Emerging Role of Autologous CD19 CAR T-Cell Therapies in the Second-Line Setting for Large B-cell Lymphoma: A Game Changer?Razan Mohty, Muhamad Alhaj Moustafa, Mahmoud Aljurf, et al.
Journal of Medical Case Reports|June 29, 2022
Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case reportHasan Nassereldine, Razan Mohty, Hussein Awada, et al.
Future Oncology (London, England)|June 21, 2021
First advanced course on biomarkers in molecular and immuno-oncology in the Middle EastElissar Moujaess, Makram Khoury, Joseph Zouein, et al.
Blood Advances|July 27, 2022
Gender and early-career faculty disparities in hematology and oncology board review lecture seriesSebawe Syaj, Leen Al-Kraimeen, Marah Akhdar, et al.
Bone Marrow Transplantation|December 15, 2023
Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapySamantha El Warrak, Mohamed A Kharfan-Dabaja, Madiha Iqbal, et al.
Journal of Hematology & Oncology|August 31, 2022
Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk diseaseRazan Mohty, Rama Al Hamed, Ali Bazarbachi, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 31, 2021
Frequency of ABCB1 C3435T and CYP3A5*3 Genetic Polymorphisms in the Lebanese PopulationAline Milane, Georges Khazen, Layal Olaywan, et al.
Clinical Hematology International|May 31, 2024
Chimeric Antigen Receptor T-cell Therapy for Chronic Lymphocytic Leukemia: What is the supporting evidence so far?Razan Mohty, Shaykha Alotaibi, Martha Gadd, et al.
Blood Cancer Journal|July 10, 2021
Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapiesRazan Mohty, Rémy Dulery, Abdul Hamid Bazarbachi, et al.
Transplantation and Cellular Therapy|June 7, 2025
Malignancies after Chimeric Antigen Receptor T Cell TherapyRazan Mohty, Amal Halwani, Talha Badar, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Hematology/Oncology and Stem Cell Therapy|November 17, 2022
Emerging Role of Autologous CD19 CAR T-Cell Therapies in the Second-Line Setting for Large B-cell Lymphoma: A Game Changer?Razan Mohty, Muhamad Alhaj Moustafa, Mahmoud Aljurf, et al.
Journal of Medical Case Reports|June 29, 2022
Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case reportHasan Nassereldine, Razan Mohty, Hussein Awada, et al.
Future Oncology (London, England)|June 21, 2021
First advanced course on biomarkers in molecular and immuno-oncology in the Middle EastElissar Moujaess, Makram Khoury, Joseph Zouein, et al.
Blood Advances|July 27, 2022
Gender and early-career faculty disparities in hematology and oncology board review lecture seriesSebawe Syaj, Leen Al-Kraimeen, Marah Akhdar, et al.
Bone Marrow Transplantation|December 15, 2023
Therapeutic options for large B-cell lymphoma relapsing after CD19-directed CAR T-cell therapySamantha El Warrak, Mohamed A Kharfan-Dabaja, Madiha Iqbal, et al.
Journal of Hematology & Oncology|August 31, 2022
Treatment of myelodysplastic syndromes in the era of precision medicine and immunomodulatory drugs: a focus on higher-risk diseaseRazan Mohty, Rama Al Hamed, Ali Bazarbachi, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 31, 2021
Frequency of ABCB1 C3435T and CYP3A5*3 Genetic Polymorphisms in the Lebanese PopulationAline Milane, Georges Khazen, Layal Olaywan, et al.
Clinical Hematology International|May 31, 2024
Chimeric Antigen Receptor T-cell Therapy for Chronic Lymphocytic Leukemia: What is the supporting evidence so far?Razan Mohty, Shaykha Alotaibi, Martha Gadd, et al.
Blood Cancer Journal|July 10, 2021
Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapiesRazan Mohty, Rémy Dulery, Abdul Hamid Bazarbachi, et al.
Transplantation and Cellular Therapy|June 7, 2025
Malignancies after Chimeric Antigen Receptor T Cell TherapyRazan Mohty, Amal Halwani, Talha Badar, et al.
Pageof 5